Home/Immatics Biotechnologies/Venkat Ramanan, Ph.D.
VR

Venkat Ramanan, Ph.D.

Chief Financial Officer

Immatics Biotechnologies

Roles

Chief Financial OfficeratImmatics Biotechnologies
Chief Financial OfficeratImmatics

Therapeutic Areas

Immatics Biotechnologies Pipeline

DrugIndicationPhase
IMA203PRAME-positive solid tumorsPhase 1/2
IMA203CD8PRAME-positive solid tumorsPhase 1/2
IMA402PRAME-positive solid tumorsPhase 1/2
IMA204Undisclosed solid tumorsPhase 1